Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells

Abstract

The purpose of this research was to develop novel nanoparticles (NPs) of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS (M-PLA-TPGS) for paclitaxel delivery for prostate cancer treatment, and evaluate their therapeutic effects in prostate cancer cell line and animal model in comparison with the linear PLGA NPs and poly(lactide)-vitamin E TPGS (PLA-TPGS) NPs. The paclitaxel-loaded M-PLA-TPGS NPs, prepared by a modified nano-precipitation method, were observed by FESEM to be near-spherical shape with narrow size distribution. The drug-loaded NPs were further characterized in terms of size, surface charge, drug content, encapsulation efficiency and in vitro drug release. The results showed that the M-PLA-TPGS NPs were found to be stable, showing almost no change in particle size and surface charge during the three-month storage period. In vitro drug release exhibited biphasic pattern with initial burst release followed by slow and continuous release. The cellular uptake level of M-PLA-TPGS NPs was demonstrated higher than linear PLGA NPs and PLA-TPGS NPs in PC-3 cells. The data also showed that the paclitaxel-loaded M-PLA-TPGS nanoparticles have higher antitumor efficacy than that of linear PLA-TPGS nanoparticles and PLGA nanoparticles in vitro and in vivo. In summary, the star-like copolymer M-PLA-TPGS could be used as a potential and promising molecular biomaterial in developing novel nanoformulation for prostate cancer treatment.

Keywords

Star-like copolymer paclitaxel prostate cancer nanoparticles drug delivery

Get full access to this article

View all access options for this article.

References

Zhang

Tan

Feng

. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 2012; 33: 4889–4906.

Zhang

Mei

Feng

. Vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine 2012; 7: 1645–1647.

Yan

Zhang

Zheng

. The effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine:NBM 2010; 6: 170–178.

Zheng

Zeng

. Novel paclitaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Int J Nanomed 2011; 6: 2679–2688.

Sanna

Sechi

. Nanoparticle therapeutics for prostate cancer treatment. Nanomedicine 2012; 8: S31–S36.

Tomasina

Lheureux

Gauduchon

. Nanocarriers for the targeted treatment of ovarian cancers. Biomaterials 2013; 34: 1073–1101.

Zeng

Tao

Mei

. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 2013; 34: 6058–6067.

Liu

Zhao

. Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials 2012; 33: 7519–7529.

Thamake

Raut

Gryczynski

. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials 2012; 33: 7164–7173.

10.

Park

Kim

Kang

. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Biomaterials 2012; 33: 8848–8857.

11.

Yang

Jiang

. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases. J Biomed Nanotechnol 2013; 9: 1617–1623.

12.

Fox

Szoka

Frechet

AMJ

. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 2009; 42: 1141–1151.

13.

Cuon

Hsieh

. Targeted delivery of doxorubicin to human prostate cancers by folate-decorated star-like PEG–PCL micelle. J Mater Chem 2012; 22: 1006–1020.

14.

Kesselman

Talmon

. Multicompartment micelles from ABC miktoarm stars in water. Science 2004; 306: 98–101.

15.

Lapienis

. Star-like polymers having PEO arms. Prog Polym Sci 2009; 34: 852–892.

16.

Ouyang

Liu

Zhao

. Synthesis and characterization of star-like poly(lactide-co-glycolide) and its drug-loaded microspheres. Polym Bull 2012; 68: 27–36.

17.

Zhang

Cheng

Wang

. Miktoarm copolymers bearing one poly(ethylene glycol) chain and several poly(epsilon-caprolactone) chains on a hyperbranched polyglycerol core. Macromolecules 2010; 43: 6671–6677.

18.

Mei

Jiang

Feng

. Star-shaped block polymers as a molecular biomaterial for nanomedicine development. Nanomedicine 2014; 9: 9–12.

19.

Lapienis

. Functionalizedstar-like polymers having PEO and/or polyglycidylarms and their properties. Polymer 2009; 50: 77–84.

20.

Tao

Zeng

Liu

. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater 2013; 9: 8910–8920.

21.

Song

Vieille

. Recent advances in the biological production of mannitol. Appl Microbiol Biotechnol 2009; 84: 55–62.

22.

Huang

Song

. Nanoparticle formulation of poly(ɛ-caprolactone-co-lactide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for Prostate cancer treatment. Polymer 2010; 51: 5952–5959.

23.

Guo

Gao

. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011; 32: 8010–8020.

24.

Zhu

. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b- poly(ɛ-caprolactone) nanoparticles: Preparation and antitumor activity in vivo. J Control Release 2010; 142: 438–446.

25.

Lee

Han

Park

. Sol–Gel transition behavior of biodegradable three-arm and four-arm star-shaped PLGA–PEG block copolymer aqueous solution. J Polym Sci Part A: Polym Chem 2006; 44: 888–899.

26.

Schubert

Delaney

Schubert

. Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid). Soft Matter 2011; 7: 1581–1588.

27.

Perrault

Walkey

Jennings

. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 2009; 9: 1909–1915.

28.

Zheng

Liu

. Nanoparticles of poly(lactide-co-glycolide)-d-a- tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett 2010; 5: 1161–1169.

29.

Fang

Bhattarai

Sun

. Functionalized nanoparticles with long-term stability in biological media. Small 2009; 5: 1637–1641.

30.

Muthu

Kulkarni

Raju

. Theranostic liposomes of TPGS coating for targeted co-delivery of paclitaxel and quantum dots. Biomaterials 2012; 33: 3494–3501.

31.

Baimark

Srisa-ard

. Preparation of drug-loaded microspheres of linear and star-like poly(D,L-lactide)s and their drug release behaviors. J Appl Polym Sci 2012; 124: 3871–3878.

32.

Feng

Mei

Anitha

. Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Paclitaxel. Biomaterials 2009; 30: 3297–3306.

33.

Rejman

Oberle

Zuhorn

. Size-dependent internalization of particle via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004; 377: 159–169.

34.

Zhang

Tang

Sun

. A novel paclitaxel-loaded poly(ɛ-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater 2010; 6: 2045–2052.

35.

Wang

Sun

Chen

. Star-like-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials 2012; 33: 6877–6888.

36.

Zheng

Chen

Zeng

. Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy. Nanoscale Res Lett 2013; 8: 161–161.

37.

Qiu

Song

. Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer. Nanoscale Res Lett 2012; 7: 666–666.